DRAGHIA-AKLI RUXANDRA has a total of 11 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are SOLVAY BIOLOGICALS BV, ALTIMMUNE INC and IMMUNE TARGETING SYSTEMS ITS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Draghia-Akli Ruxandra | 11 |
#2 | Khan Amir S | 3 |
#3 | Weiner David B | 3 |
#4 | Yan Jian | 2 |
#5 | Pope Melissa | 2 |
#6 | Brown Patricia | 1 |
#7 | Sardesai Niranjan Y | 1 |
#8 | Hood David | 1 |
#9 | Carpenter Robert H | 1 |
#10 | Fiorroto Marta L | 1 |
Publication | Filing date | Title |
---|---|---|
US2008269153A1 | Increased stability of a dna formulation by including poly-l-glutamate | |
US2010010467A1 | Growth hormone releasing hormone treatment to decrease cholesterol levels |